• Walther Birkmayer
  • Peter Riederer


There is hardly any book on Parkinson’s disease which starts without reference to the “Essay on the shaking palsy”, in which James Parkinson, in 1817, first described this disorder of motor function. We would propose the first therapeutic advance to be that of Charcot (1892), who introduced treatment with the Solanaceae. This Atropa belladonna medication was practically the only available treatment until the introduction of the synthetic anticholinergic drugs (Sigwald et al. 1946). While the first autopsy finding was of a post-apoplectic cyst in the right thalamus (Oppolzer 1861), the decisive neuropathological observation was the description of a case of Parkinson’s disease with a tubercle of the substantia nigra (Blocq and Marinesco 1894).


Idiopathic Parkinsonism Parkinsonian Syndrome Parkinsonian Symptom Encephalitis Lethargica Oculogyric Crisis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Wien 1983

Authors and Affiliations

  • Walther Birkmayer
    • 1
  • Peter Riederer
    • 2
  1. 1.Ludwig Boltzmann-Institutes für NeurochemieWienAustria
  2. 2.Ludwig Boltzmann-Institut für Klinische Neurobiologie, Arbeitsgruppe NeurochemieKrankenhaus der Stadt Wien-LainzWienAustria

Personalised recommendations